These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 462386)

  • 1. [New aspects in the management of overweight diabetics].
    Brumby KH
    Ther Ggw; 1979 Apr; 118(4):558-66. PubMed ID: 462386
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypoglycemic action of fenfluramine in obese diabetics].
    De Sereday MS; Efron HR; De Compte DV; Raffo del Campo MA
    Prensa Med Argent; 1971 Jul; 58(20):1030-3. PubMed ID: 4938286
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenfluramine in management of obese diabetics.
    Misra NP; Bhambal SA; Yesikar SS; Bellani RK
    J Assoc Physicians India; 1980 Sep; 28(9):287-95. PubMed ID: 7007309
    [No Abstract]   [Full Text] [Related]  

  • 4. A trial of fenfluramine (PACaps) and diet in overweight diabetic patients.
    Wells HM
    Postgrad Med J; 1975; 51 Suppl 1(593):137. PubMed ID: 1219672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is fenfluramine suitable as a therapeutic principle in obese aged diabetics? (end)].
    Förster H; Huth K; Koch E; Tunali G
    Fortschr Med; 1979 Feb; 97(6):259-62. PubMed ID: 428867
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of new formulation of fenfluramine in the management of the obese, diabetic African.
    Wilton D
    Postgrad Med J; 1975; 51 Suppl 1():138-9. PubMed ID: 1219673
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenformin compared with fenfluramine in the treatment of obese diabetic patients.
    Kesson CM; Ireland JT
    Practitioner; 1976 May; 216(1295):577-80. PubMed ID: 781656
    [No Abstract]   [Full Text] [Related]  

  • 8. 780SE in the management of disorders of lipid and glucose metabolism.
    Riveline B
    Postgrad Med J; 1975; 51 Suppl 1():162-4. PubMed ID: 1219674
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative unresponsiveness of obese diabetic compared to obese non-diabetic subjects to the weight-reducing effect of fenfluramine.
    Otim MA
    East Afr Med J; 1977 Feb; 54(2):91-5. PubMed ID: 885093
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypoglycemic effect of fenfluramine in insulin-treated diabetics.
    Hamet P; Verdy I; Chiasson JL; Verdy M
    Clin Invest Med; 1986; 9(1):12-4. PubMed ID: 3514018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of the obese non-insulin-dependent patient with d-fenfluramine].
    Daniele E; Coco MP
    Clin Ter; 1996 Apr; 147(4):199-204. PubMed ID: 8766352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.
    Khan M; Lum CT; Rao V
    Transplant Proc; 1995 Feb; 27(1):975-6. PubMed ID: 7879251
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of diabetes mellitus treated with insulin and oral hypoglycemic agents in Denmark.
    Nielsen NV; Hemmingsen L
    Diabetes Res; 1986 Oct; 3(8):423-5. PubMed ID: 3545623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Fenfluramine in complicated obesity.
    Wilton TD
    S Afr Med J; 1974 Jun; 48(31):1324. PubMed ID: 4846424
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetes mellitus. XII. Oral diabetes therapy].
    Bruns W; Michaelis D; Wappler E
    Z Arztl Fortbild (Jena); 1971 Feb; 65(3):125-30. PubMed ID: 5575105
    [No Abstract]   [Full Text] [Related]  

  • 16. Recognition and management of secondary failure to oral hypoglycemic agents.
    Gebhardt MC; Garnett WR; Pulliam CC
    Am J Hosp Pharm; 1974 Dec; 31(12):1212-6. PubMed ID: 4458440
    [No Abstract]   [Full Text] [Related]  

  • 17. The action of fenfluramine in diabetes mellitus.
    Joasoo A; Turtle JR
    Postgrad Med J; 1975; 51 Suppl 1():133. PubMed ID: 1219670
    [No Abstract]   [Full Text] [Related]  

  • 18. New data on Adebit treatment of diabetes.
    Pogátsa G
    Ther Hung; 1971; 19(2):73-7. PubMed ID: 5172876
    [No Abstract]   [Full Text] [Related]  

  • 19. [Oral hypoglycemic agents].
    Mirouze J
    Rev Clin Esp; 1978 Mar; 148(6):575-8. PubMed ID: 663333
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fenfluramine as an oral antidiabetic].
    Hepp KD
    MMW Munch Med Wochenschr; 1983 Nov; 125(46):126-7. PubMed ID: 6417535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.